Fetomaternal alloimmune thrombocytopenia: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
Line 5: Line 5:
In '''fetomaternal alloimmune thrombocytopenia''' (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for [[platelet]] antigens) pass through the [[placenta]] and attack platelets in the fetal circulation.  This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed.  Medical treatment is problematic.
In '''fetomaternal alloimmune thrombocytopenia''' (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for [[platelet]] antigens) pass through the [[placenta]] and attack platelets in the fetal circulation.  This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed.  Medical treatment is problematic.


{{SIB}}
 


[[Category:Obstetrics]]
[[Category:Obstetrics]]

Revision as of 02:40, 9 August 2012

WikiDoc Resources for Fetomaternal alloimmune thrombocytopenia

Articles

Most recent articles on Fetomaternal alloimmune thrombocytopenia

Most cited articles on Fetomaternal alloimmune thrombocytopenia

Review articles on Fetomaternal alloimmune thrombocytopenia

Articles on Fetomaternal alloimmune thrombocytopenia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fetomaternal alloimmune thrombocytopenia

Images of Fetomaternal alloimmune thrombocytopenia

Photos of Fetomaternal alloimmune thrombocytopenia

Podcasts & MP3s on Fetomaternal alloimmune thrombocytopenia

Videos on Fetomaternal alloimmune thrombocytopenia

Evidence Based Medicine

Cochrane Collaboration on Fetomaternal alloimmune thrombocytopenia

Bandolier on Fetomaternal alloimmune thrombocytopenia

TRIP on Fetomaternal alloimmune thrombocytopenia

Clinical Trials

Ongoing Trials on Fetomaternal alloimmune thrombocytopenia at Clinical Trials.gov

Trial results on Fetomaternal alloimmune thrombocytopenia

Clinical Trials on Fetomaternal alloimmune thrombocytopenia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fetomaternal alloimmune thrombocytopenia

NICE Guidance on Fetomaternal alloimmune thrombocytopenia

NHS PRODIGY Guidance

FDA on Fetomaternal alloimmune thrombocytopenia

CDC on Fetomaternal alloimmune thrombocytopenia

Books

Books on Fetomaternal alloimmune thrombocytopenia

News

Fetomaternal alloimmune thrombocytopenia in the news

Be alerted to news on Fetomaternal alloimmune thrombocytopenia

News trends on Fetomaternal alloimmune thrombocytopenia

Commentary

Blogs on Fetomaternal alloimmune thrombocytopenia

Definitions

Definitions of Fetomaternal alloimmune thrombocytopenia

Patient Resources / Community

Patient resources on Fetomaternal alloimmune thrombocytopenia

Discussion groups on Fetomaternal alloimmune thrombocytopenia

Patient Handouts on Fetomaternal alloimmune thrombocytopenia

Directions to Hospitals Treating Fetomaternal alloimmune thrombocytopenia

Risk calculators and risk factors for Fetomaternal alloimmune thrombocytopenia

Healthcare Provider Resources

Symptoms of Fetomaternal alloimmune thrombocytopenia

Causes & Risk Factors for Fetomaternal alloimmune thrombocytopenia

Diagnostic studies for Fetomaternal alloimmune thrombocytopenia

Treatment of Fetomaternal alloimmune thrombocytopenia

Continuing Medical Education (CME)

CME Programs on Fetomaternal alloimmune thrombocytopenia

International

Fetomaternal alloimmune thrombocytopenia en Espanol

Fetomaternal alloimmune thrombocytopenia en Francais

Business

Fetomaternal alloimmune thrombocytopenia in the Marketplace

Patents on Fetomaternal alloimmune thrombocytopenia

Experimental / Informatics

List of terms related to Fetomaternal alloimmune thrombocytopenia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In fetomaternal alloimmune thrombocytopenia (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for platelet antigens) pass through the placenta and attack platelets in the fetal circulation. This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed. Medical treatment is problematic. Template:WH Template:WikiDoc Sources